Evidence map›Paper›PMID 36209156›Full record

ArticleNature communications2022

A supraparticle-based biomimetic cascade catalyst for continuous flow reaction.

Xiaomiao Guo, Nan Xue, Ming Zhang, Rammile Ettelaie, Hengquan Yang

Abstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Biomimetic Chiral Nanomaterials with Selective Catalysis Activity.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Xiaomiao Guo *School of Chemistry and Chemical Engineering, Shanxi University, 030006, Taiyuan, China.
Nan Xue *School of Chemistry and Chemical Engineering, Shanxi University, 030006, Taiyuan, China.
Ming ZhangSchool of Chemistry and Chemical Engineering, Shanxi University, 030006, Taiyuan, China.ORCID 0000-0001-9917-127X
Rammile EttelaieFood Colloids Group, School of Food Science and Nutrition, University of Leeds, Leeds, LS2 9JT, UK.ORCID 0000-0002-6970-4650
Hengquan YangSchool of Chemistry and Chemical Engineering, Shanxi University, 030006, Taiyuan, China. hqyang@sxu.edu.cn.ORCID 0000-0001-7955-0512

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Robust millimeter-sized spherical particles with controlled compositions and microstructures hold promises of important practical applications especially in relation to continuous flow cascade catalysis. However, the efficient fabrication methods for producing such particles remain scare. Here, we demonstrate a liquid marble approach to fabricate robust mm-sized porous supraparticles (SPs) through the bottom-up assembly of silica nanoparticles in the presence of strength additive or surface interactions, without the need for the specific liquid-repellent surfaces used by the existing methods. As the proof of the concept, our method was exemplified by fabricating biomimetic cascade catalysts through assembly of two types of well-defined catalytically active nanoparticles. The obtained SP-based cascade catalysts work well in industrially preferred fixed-bed reactors, exhibiting excellent catalysis efficiency, controlled reaction kinetics, high enantioselectivity (99% ee) and outstanding stability (200~500 h) in the cascades of ketone hydrogenation-kinetic resolution and amine racemization-kinetic resolution. The excellent catalytic performances are attributed to the structural features, reconciling close proximity of different catalytic sites and their sufficient spatial isolation.

Indexed as

BiomimeticsSilicon DioxideAminesCalcium CarbonateCatalysisKetonesAminesCalcium CarbonateKetonesSilicon Dioxide

Identifiers

PMID36209156
PMCPMC9547976

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.